Regeneron Pharmaceuticals (REGN) Assets Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.78% |
| Dec 31, 2025 | 11.56% |
| Sep 30, 2025 | 13.22% |
| Jun 30, 2025 | 12.00% |
| Mar 31, 2025 | 12.53% |
| Dec 31, 2024 | 14.08% |
| Sep 30, 2024 | 16.51% |
| Jun 30, 2024 | 18.87% |
| Mar 31, 2024 | 24.59% |
| Dec 31, 2023 | 24.45% |
| Sep 30, 2023 | 25.99% |
| Jun 30, 2023 | 28.56% |
| Mar 31, 2023 | 24.02% |
| Dec 31, 2022 | 25.43% |
| Sep 30, 2022 | 25.69% |
| Jun 30, 2022 | 27.35% |
| Mar 31, 2022 | 27.03% |
| Dec 31, 2021 | 29.42% |
| Sep 30, 2021 | 29.87% |
| Jun 30, 2021 | 29.25% |
| Mar 31, 2021 | 23.77% |
| Dec 31, 2020 | 25.11% |
| Sep 30, 2020 | 22.73% |
| Jun 30, 2020 | 21.19% |
| Mar 31, 2020 | 26.32% |
| Dec 31, 2019 | 28.53% |
| Sep 30, 2019 | 26.86% |
| Jun 30, 2019 | 28.53% |
| Mar 31, 2019 | 29.61% |
| Dec 31, 2018 | 27.90% |
| Sep 30, 2018 | 27.75% |
| Jun 30, 2018 | 30.03% |
| Mar 31, 2018 | 30.69% |
| Dec 31, 2017 | 31.69% |
| Sep 30, 2017 | 32.51% |
| Jun 30, 2017 | 32.87% |
| Mar 31, 2017 | 33.84% |
| Dec 31, 2016 | 33.20% |
| Sep 30, 2016 | 37.26% |
| Jun 30, 2016 | 37.67% |
| Mar 31, 2016 | 37.41% |
| Dec 31, 2015 | 39.18% |
| Sep 30, 2015 | 46.14% |
| Jun 30, 2015 | 45.90% |
| Mar 31, 2015 | 45.96% |
| Dec 31, 2014 | 42.60% |
| Sep 30, 2014 | 56.10% |
| Jun 30, 2014 | 48.90% |
| Mar 31, 2014 | 44.78% |
| Dec 31, 2013 | 39.40% |
| Sep 30, 2013 | 40.97% |
| Jun 30, 2013 | 44.35% |
| Dec 31, 2012 | 41.06% |